MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 31 filers reported holding MILESTONE PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,932,044 | +8.9% | 2,558,724 | +0.1% | 0.00% | +100.0% |
| Q2 2023 | $7,282,568 | -27.6% | 2,555,287 | +0.1% | 0.00% | -50.0% |
| Q1 2023 | $10,056,712 | -4.1% | 2,552,465 | -3.6% | 0.00% | 0.0% |
| Q4 2022 | $10,482,579 | +991.9% | 2,647,116 | +2433.2% | 0.00% | – |
| Q3 2022 | $960,000 | +1197.3% | 104,497 | +770.5% | 0.00% | – |
| Q2 2022 | $74,000 | -3.9% | 12,004 | 0.0% | 0.00% | – |
| Q1 2022 | $77,000 | -2.5% | 12,004 | 0.0% | 0.00% | – |
| Q4 2021 | $79,000 | +14.5% | 12,004 | 0.0% | 0.00% | – |
| Q3 2021 | $69,000 | +4.5% | 12,004 | 0.0% | 0.00% | – |
| Q2 2021 | $66,000 | -5.7% | 12,004 | 0.0% | 0.00% | – |
| Q1 2021 | $70,000 | -53.0% | 12,004 | -46.0% | 0.00% | – |
| Q4 2020 | $149,000 | +69.3% | 22,250 | +85.4% | 0.00% | – |
| Q3 2020 | $88,000 | – | 12,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 2,530,585 | $16,955,000 | 0.73% |
| Ikarian Capital, LLC | 1,836,545 | $12,305,000 | 0.54% |
| Boxer Capital, LLC | 2,477,194 | $16,597,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,911,000 | 0.48% |
| RA Capital Management | 2,327,714 | $15,596,000 | 0.22% |
| Orbimed Advisors | 2,493,109 | $16,704,000 | 0.15% |
| PURA VIDA INVESTMENTS, LLC | 450,000 | $3,015,000 | 0.11% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,704,000 | 0.08% |
| Anson Funds Management LP | 50,113 | $336,000 | 0.07% |
| Tekla Capital Management LLC | 253,610 | $1,699,000 | 0.06% |